In this photo provided by Pfizer, a technician inspects filled vials of the Pfizer-BioNTech Covid-19 vaccine at the company’s facility in Puurs, Belgium in March 2021.DESPITE having a young population and a current dependence on imported vaccines, the Philippines would gain from having its own vaccine manufacturing industry. However, it will take more time and investments to make this happen, according to the World Bank.
“It is also preparing for an upcoming WHO GBT audit by working to address challenges identified during a previous audit. Facility and manpower needs have been identified and the PFDA [Philippine FDA] is working to address them through ongoing capacity-building efforts. Achievement of ML3 status would enable the Philippines to better support and participate in regional vaccine efforts,” the World Bank said.
The FDA, World Bank said, has received an overall rating of ML1, though some functions received higher scores than others. The national regulatory system, registration and marketing, and clinical trials oversight were rated ML1. The report also noted that a number of pharmaceutical companies in the Philippines have the potential to manufacture vaccines. However, certain concerns prevent them from doing so.
The World Bank also noted a need to capacitate human resources with required technical skills for vaccine manufacturing and to build relationships with external partners to support technology transfer.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BusinessMirror - 🏆 19. / 59 Read more »
Source: BusinessMirror - 🏆 19. / 59 Read more »